Assessment of the efficacy of Saffron on happiness and quality of life in healthy adults

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200813048396N1

Enrollment

Registered

2021-01-10

Start date

2021-01-19

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy people.

Interventions

Intervention 1: Intervention group: Saffron in the form of 500 mg capsules containing 75 mg of saffron powder and 425 mg of bread powder, which is packed in 42 cans in the Clinical Research Center of

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Indivisual's mental health ( indivisuals with scores lower than 7 in the depression section of GHQ mental health questionnaire , who will be referred to as "healthy indivisuals" in his study Obtaining informed consent

Exclusion criteria

Exclusion criteria: History of mental disease according to GHQ mental health questionnaire Pregnancy or lactation

Design outcomes

Primary

Measure	Time frame
Change in happiness questionnaire score. Timepoint: Before intervention, Two weeks after starting the study. Method of measurement: Oxford questionnaire.;Change in quality of life questionnaire score. Timepoint: Before intervention, Two weeks after starting the study. Method of measurement: SF-36 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Keyhan Soltani Hosseini

Shahed University

mksoltani47@yahoo.com+98 21 2258 9176

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026